Articles tagged with Thyroid Cancer
A study of 872 young adults found that 14.4% borrowed over $10,000 due to illness or treatment, while 54% experienced mental task impairment. Cancer treatment with chemotherapy increased the risk of these issues significantly.
A new retrospective study shows that thyroid surgery readmissions are highest within a week of the procedure, with patients experiencing severe symptoms such as tremors and muscle spasms being most at risk. The study identifies risk factors that can be addressed to prevent these readmissions, including timely follow-up using telehealth.
A genetic test called ThyroSeq has been shown to reliably distinguish between benign and cancerous thyroid nodules using a small sample of cells. The test correctly identified cancerous nodules as positive 94% of the time and detected benign nodules as negative 82% of the time, preventing unnecessary diagnostic surgeries.
The HiLo trial found no significant difference in recurrence rates between patients given a low radiation dose compared to the standard higher dose. This means patients with low-risk thyroid cancer can benefit from fewer side effects, long-term complications, and more convenient treatment options.
A recent study published online demonstrated that Droplet Digital PCR technology can detect and quantify rare mutations in the TERT promoter region with high sensitivity. The assays detected the mutation in 78% of samples and yielded no false positives, showing its potential as a biomarker for diagnosing and monitoring patients.
The revised guidelines have led to a significant increase in hemithyroidectomy procedures, with benefits including lower complication rates, reduced hospital stays, and lower costs. The procedure is now considered an equal option to total thyroidectomy for many patients, offering improved outcomes and more personalized care.
Livia Schiavinato Eberlin has developed the MasSpec Pen, a tool that enables surgeons to rapidly differentiate cancerous tissue from healthy tissue in patients. Her research aims to improve cancer diagnoses and treatment options using mass spectrometry imaging.
Pericytes, supporting blood vessels, may trigger tumor cell resistance to therapy by releasing molecules. Targeting these factors could represent a novel approach for aggressive tumors resistant to conventional treatments.
A microRNA panel developed by researchers identified 19 microRNAs that can categorize indeterminate thyroid nodule samples into malignant and benign. The panel showed high sensitivity, specificity, and accuracy in diagnosing cancer in patients with suspicious thyroid nodules.
Thyroid cancer incidence has tripled in the US over 25 years, with over 50,000 people diagnosed annually. Experts propose measures to reduce overtreatment, such as active surveillance for small papillary thyroid cancers and more conservative surgical approaches like lobectomy.
A new study from Harvard T.H. Chan School of Public Health found that US flight attendants have a higher prevalence of several cancers, including breast and cervical cancer, compared to the general public. The study suggests that minimizing radiation exposure and circadian rhythm disruption may help reduce the risk of cancer among cabi...
A new study finds that male thyroid cancer survivors have a nearly 50% higher risk of developing heart disease than women. Additionally, thyroid cancer survivors with obesity have a 41% higher risk of cardiovascular disease.
Researchers discovered a new strategy against anaplastic thyroid cancer using stereotactic body radiation therapy (SBRT), which showed better results than conventional radiotherapy. The study was made possible by a patient's donation of $10,000 to fund research.
A Loyola Medicine study found that new ultrasound guidelines can reliably identify children who need a biopsy for thyroid cancer. The American College of Radiology's system grades nodules on a scale, with higher scores indicating more suspicious cancer.
A large-scale study of thyroid cancer genetics has identified specific genes driving the disease and found that certain cancers can benefit from immunotherapy. The research also found amplifications of key receptor tyrosine kinases in anaplastic thyroid cancers, suggesting a potential target for treatment with lenvatinib.
Two studies and an editorial report confirm that firefighters exposed to the World Trade Center's aftermath are at a heightened risk of developing cancer. The research highlights the environmental exposures to carcinogens in the wreckage, which poses significant health concerns for those who responded to the 9/11 attacks.
A phase I clinical trial of BLU-667, a novel precision-targeted drug, reports significant durable disease control in patients with RET-driven cancers. The study reveals an overall response rate of 37% for RET-driven cancers, with responses of 45% for non-small cell lung cancer.
A new study of 45 years reveals that Alaska Natives have a similar incidence of thyroid cancer as the U.S. white population, but their tumors tend to be larger and have spread beyond a localized area. The study suggests that differences in access to healthcare may contribute to these discrepancies.
In a Penn-led trial, cabozantinib significantly shrunk tumors in 34 out of 35 patients with metastatic, radioactive iodine-resistant thyroid cancer. The median time on the study was 35 weeks, and 54% of patients achieved a partial response.
Researchers have identified 52 microRNAs that are decreased in expression as thyroid cancer becomes more aggressive. Restoring these molecules' levels in tumors may be a novel treatment strategy.
Researchers in Japan propose updated diagnostic criteria, revised patient management and treatment guidelines, and new algorithms for thyroid storm. The most common cause of death is multiple organ failure, highlighting the need for further studies on TS outcomes and prognosis.
Researchers detected a high rate of thyroid cancer in young individuals from Fukushima Prefecture after the 2011 nuclear accident. However, no clear evidence suggests an increased incidence of thyroid carcinomas following the accident, contrasting with Chernobyl's findings.
Researchers at Harvard Medical School have discovered a novel therapeutic strategy to treat drug-resistant thyroid cancers by combining vemurafenib with palbociclib, a CDK4/6 inhibitor. The treatment was shown to induce stronger cell death than when used alone, offering new hope for patients with papillary thyroid carcinoma.
A review article reveals that thyroid hormones and biochemical pathways drive seasonal reproduction in some mammals. The study suggests that increased triiodothyronine (T3) levels regulate gonadotropin-releasing hormone secretion in a seasonal fashion.
A 10-year study of over 1,200 patients with low-risk PMC of the thyroid found that close monitoring is an acceptable first-line approach, reducing unnecessary surgery. The study showed that only 8% of patients experienced tumor growth or new metastasis, and older patients were least likely to grow.
A study found that thyroid cancer survivors are at increased risk of many aging-related diseases, including diabetes, heart disease, and osteoporosis. Those diagnosed with thyroid cancer before age 40 had the highest risk for some of these diseases.
A new ultrasound scoring system has been developed to identify thyroid nodules that require biopsy or follow-up. The system uses a risk stratification approach to classify nodule appearance and size, reducing unnecessary biopsies and improving cancer diagnosis accuracy.
New research from the University of Pennsylvania School of Medicine finds that lenvatinib improves overall survival rates in older thyroid cancer patients who are resistant to standard radioiodine treatment. The drug is well-tolerated and has a significant impact on patient outcomes.
A study published in the New England Journal of Medicine found that wealthier individuals are more likely to receive cancer diagnoses due to increased testing. However, mortality rates from these cancers have been decreasing, largely due to improved treatments. The authors suggest alternative payment models and reduced financial confli...
Researchers found that two FDA-approved immunotherapy drugs, dabrafenib and trametinib, are well-tolerated and result in a 50-54% response rate among patients with advanced BRAF-mutated papillary thyroid cancer. This breakthrough could change the standard of care for this rare but aggressive form of thyroid cancer.
A study by Penn State researchers suggests a possible link between the partial meltdown at Three Mile Island Nuclear Power Plant and thyroid cancer cases in nearby areas. The study found an increase in genetic mutations caused by low-dose radiation exposure in patients who developed thyroid cancer after living in at-risk regions.
A large population-based study found that 6.5% of thyroid cancer patients experienced general post-operative complications, while 12% had complications specific to thyroid surgery within a year after their operation. Patients over 65 and those with more advanced thyroid cancer were at higher risk for these complications.
The USPSTF concludes that screening for thyroid cancer in asymptomatic persons results in harms that outweigh the benefits due to overdiagnosis and overtreatment. Most cases of thyroid cancer have a good prognosis with a 98.1% 5-year survival rate.
A new study published in the Journal of the American College of Surgeons found that pancreatic cancer patients who travel to academic medical centers for surgery have longer overall survival rates and better quality care. For thyroid cancer patients, traveling also results in more adherence to evidence-based treatment guidelines.
A large study found patients with follicular and medullary thyroid cancer had the highest rate of bone lesions and fractures, and increased risk of death. Researchers suggest targeting this high-risk population with specific drugs to prevent or treat complications.
Sub-Saharan African-born blacks experience a higher incidence of infection-related cancers and blood cancers compared to US-born non-Hispanic blacks. In contrast, prostate cancer is more prevalent among Western African-born black men, while Eastern African-born blacks have higher rates of liver and thyroid cancer.
A study found that the 2006 Massachusetts health reform led to a significant increase in surgical intervention for thyroid cancer, particularly among nonwhite patients. The researchers discovered a 26% rise in thyroidectomy rates and a 22% increase in neck dissections among these patients compared to those with private insurance.
A combination of two drugs targeting molecular pathways controlled by the RAS gene has shown promise in treating RAS-driven lung, ovarian, and thyroid cancers. Patients with heavily treated cancers have experienced long-term clinical benefit from the treatment, including one patient on treatment for over two years.
A study by the Endocrine Society found that higher exposure to certain flame retardants may be associated with an increased risk of papillary thyroid cancer. The researchers collected dust samples from homes and analyzed participants' blood samples to assess long-term exposure to these environmental chemicals.
Research reveals that consuming cow's milk with levothyroxine supplement can lead to reduced absorption of the medication, potentially resulting in inadequate thyroid hormone levels. The study advises patients on managing hypothyroidism or taking levothyroxine to avoid consuming dairy products simultaneously.
Thyroid cancer incidence has increased in the US, with higher rates among Hispanics and African Americans compared to non-Hispanic Whites. The study found a significant rise in incidence among young people, particularly Hispanic females between 20-49 years old.
A new study by Cleveland Clinic researchers found that the rarely studied gene USF3 is associated with an increased risk of developing differentiated thyroid cancer. The team discovered a compound heterozygous deletion in USF3 linked to the disease, which may lead to a potential therapeutic strategy by removing glutamine.
Patients with thyroid cancer who choose not to intervene report feeling isolated and anxious, despite lack of support from healthcare providers. Many keep diagnosis a secret to avoid negative feedback, but only a few find satisfactory support from others.
Researchers at the University of Pittsburgh School of Medicine have identified a novel genetic mechanism and marker that may predict response to a class of drugs in many cancer types. Elevated levels of IGF2BP3 protein were found in both thyroid and other common cancers, suggesting its potential as a biomarker for treatment response.
The American Thyroid Association has published new evidence-based recommendations for diagnosing and managing thyroid disease during pregnancy. The Guidelines cover thyroid function testing, iodine nutrition, and treatment of thyroid disease during pregnancy and lactation.
A study found a sixfold increase in thyroid cancer incidence in South Korea between 1999 and 2008, mainly due to overdetection by screening. The researchers call for reduced ultrasound examinations in the general population to mitigate the economic burden of unnecessary treatments.
A team of scientists at the University of Alberta has discovered a protein marker, PDGFRA, that can help diagnose and treat aggressive papillary thyroid cancer. This finding could lead to more targeted treatments and reduce the need for unnecessary surgeries.
For patients with suspicious papillary thyroid cancer, lobectomy is associated with better outcomes and lower costs compared to total thyroidectomy. The study used a Markov model to determine the effectiveness of each procedure in terms of quality-adjusted life years.
Researchers discovered a nearly 4-fold increase in thyroid cancer among WTC-exposed firefighters, but this increased risk was not significant after controlling for biases. A separate finding showed a 1.4-fold increase in prostate cancer among WTC-exposed firefighters from 2005 to 2009.
Research by Australian National University has found that diagnoses of differentiated thyroid cancer have increased three-fold in 25 years despite no change to death rates. Over-meticulous examinations are leading to unnecessary surgeries, causing substantial medical costs and complications for patients.
The new Guidelines, published in Thyroid Journal, offer a detailed framework for the diagnosis and management of patients with different etiologies of thyrotoxicosis. The guidelines integrate recent studies and developments in practice trends, providing a comprehensive set of recommendations.
A phase II clinical study found that treating metastatic thyroid cancer patients with the BRAF mutation showed promising anti-tumor activity in a third of patients, with an overall response rate of 38%. The therapy vemurafenib joins other effective treatments for this patient population.
A study of 28,000 patients found that increased imaging after initial treatment for thyroid cancer did not lead to better survival rates, but rather more aggressive treatment for recurrence. The researchers emphasize the importance of curbing unnecessary imaging and tailoring care to individual patient risk.
A new study found that while more imaging after thyroid cancer treatment identifies recurrence, it does not always lead to improved survival. Radioiodine scans, however, were associated with better outcomes.
A type of thyroid cancer, EFVPTC, is being reclassified as non-invasive and low-risk due to its low recurrence rate. The new name, NIFTP, guides pathologists in diagnosis and reduces aggressive treatment, potentially saving lives and reducing healthcare costs.
A recent study published by The Endocrine Society found that radioactive iodine treatment can impair a woman's remaining egg supply, known as ovarian reserve. Women who received high doses of radiation had significantly lower levels of anti-Müllerian hormone (AMH) after treatment.
A new study from Duke Health reveals that patients undergoing thyroidectomy should seek surgeons who perform at least 25 operations annually to minimize risks. The study analyzed data from over 16,000 patients and found an association between surgeon case volume and complication rates.
Researchers developed a new method called ADAP to detect antibodies in small blood samples, increasing sensitivity for early disease diagnosis. The approach could also be applied to saliva testing, offering a simpler and more accessible alternative to current methods.
Men and women in Appalachia continue to have higher cancer incidence rates compared with those in the rest of the United States. Lifestyle changes and improved healthcare are helping narrow the gap between Appalachian and non-Appalachian populations.
The new guidelines provide a comprehensive framework for the evaluation, treatment, and surveillance of patients with thyroid nodules and thyroid cancer. The updated guidelines integrate new information and advances in the field, but also highlight areas that need further investigation and refinements.